46 related articles for article (PubMed ID: 23822878)
1. FOXM1 and CHD4 expression is associated with chemoresistance in hepatoblastoma.
Hino Y; Kohashi K; Tamaki A; Kawakubo N; Hamada H; Fukuhara M; Shibui Y; Tajiri T; Oda Y
Pathol Res Pract; 2024 Jun; 258():155348. PubMed ID: 38761648
[TBL] [Abstract][Full Text] [Related]
2. Higher expression of SALL4-A isoform is correlated with worse outcomes and progression of the disease in subtype of testicular germ cell tumours.
Lakpour N; Ghods R; Abolhasani M; Saeednejad Zanjani L; Saliminejad K; Kalantari E; Saki S; Ranjbar MM; Balay-Goli L; Sadeghi MR; Madjd Z
Biomarkers; 2024 Jun; ():1-16. PubMed ID: 38808385
[TBL] [Abstract][Full Text] [Related]
3. Multiple hepatoblastomas with positive β-catenin immunostaining as a potential indication for germline APC genetic testing: A case report.
Sato T; Takata C; Ito J; Shimada H; Hasegawa T
Congenit Anom (Kyoto); 2024 May; 64(3):161-163. PubMed ID: 38419284
[No Abstract] [Full Text] [Related]
4. Two cases of hepatoblastoma in Bohring-Opitz syndrome: An emerging association.
Patel K; McQuaid S; Ketterl T; Benedetti DJ; Sokol E
Pediatr Blood Cancer; 2024 Jul; 71(7):e31010. PubMed ID: 38637906
[No Abstract] [Full Text] [Related]
5. Glypican 3 expression in pediatric malignant solid tumors.
Kinoshita Y; Tanaka S; Souzaki R; Miyoshi K; Kohashi K; Oda Y; Nakatsura T; Taguchi T
Eur J Pediatr Surg; 2015 Feb; 25(1):138-44. PubMed ID: 25344940
[TBL] [Abstract][Full Text] [Related]
6. Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium.
López-Terrada D; Alaggio R; de Dávila MT; Czauderna P; Hiyama E; Katzenstein H; Leuschner I; Malogolowkin M; Meyers R; Ranganathan S; Tanaka Y; Tomlinson G; Fabrè M; Zimmermann A; Finegold MJ;
Mod Pathol; 2014 Mar; 27(3):472-91. PubMed ID: 24008558
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic and prognostic value of SALL4 in hepatoblastoma.
Zhou S; Venkatramani R; Gomulia E; Shillingford N; Wang L
Histopathology; 2016 Nov; 69(5):822-830. PubMed ID: 27252091
[TBL] [Abstract][Full Text] [Related]
8. SALL4 expression in germ cell and non-germ cell tumors: a systematic immunohistochemical study of 3215 cases.
Miettinen M; Wang Z; McCue PA; Sarlomo-Rikala M; Rys J; Biernat W; Lasota J; Lee YS
Am J Surg Pathol; 2014 Mar; 38(3):410-20. PubMed ID: 24525512
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastoma.
Fang J; Singh S; Cheng C; Natarajan S; Sheppard H; Abu-Zaid A; Durbin AD; Lee HW; Wu Q; Steele J; Connelly JP; Jin H; Chen W; Fan Y; Pruett-Miller SM; Rehg JE; Koo SC; Santiago T; Emmons J; Cairo S; Wang R; Glazer ES; Murphy AJ; Chen T; Davidoff AM; Armengol C; Easton J; Chen X; Yang J
Nat Commun; 2023 Jul; 14(1):4003. PubMed ID: 37414763
[TBL] [Abstract][Full Text] [Related]
10. IL-34 in hepatoblastoma cells potentially promote tumor progression via autocrine and paracrine mechanisms.
Irie T; Yoshii D; Komohara Y; Fujiwara Y; Kadohisa M; Honda M; Suzu S; Matsuura T; Kohashi K; Oda Y; Hibi T
Cancer Med; 2022 Mar; 11(6):1441-1453. PubMed ID: 35132816
[TBL] [Abstract][Full Text] [Related]
11. Pro-inflammatory cytokine polymorphisms and interactions with dietary alcohol and estrogen, risk factors for invasive breast cancer using a post genome-wide analysis for gene-gene and gene-lifestyle interaction.
Jung SY; Papp JC; Sobel EM; Pellegrini M; Yu H; Zhang ZF
Sci Rep; 2021 Jan; 11(1):1058. PubMed ID: 33441805
[TBL] [Abstract][Full Text] [Related]
12. The Role of Gene Therapy in Premature Ovarian Insufficiency Management.
Atabiekov I; Hobeika E; Sheikh U; El Andaloussi A; Al-Hendy A
Biomedicines; 2018 Nov; 6(4):. PubMed ID: 30388808
[TBL] [Abstract][Full Text] [Related]
13. SALL1 functions as a tumor suppressor in breast cancer by regulating cancer cell senescence and metastasis through the NuRD complex.
Ma C; Wang F; Han B; Zhong X; Si F; Ye J; Hsueh EC; Robbins L; Kiefer SM; Zhang Y; Hunborg P; Varvares MA; Rauchman M; Peng G
Mol Cancer; 2018 Apr; 17(1):78. PubMed ID: 29625565
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular malignant neoplasm, NOS: a clinicopathological study of 11 cases from a single institution.
Zhou S; Venkatramani R; Gupta S; Wang K; Stein JE; Wang L; Mascarenhas L
Histopathology; 2017 Nov; 71(5):813-822. PubMed ID: 28660626
[TBL] [Abstract][Full Text] [Related]
15. Targeting SALL4 by entinostat in lung cancer.
Yong KJ; Li A; Ou WB; Hong CK; Zhao W; Wang F; Tatetsu H; Yan B; Qi L; Fletcher JA; Yang H; Soo R; Tenen DG; Chai L
Oncotarget; 2016 Nov; 7(46):75425-75440. PubMed ID: 27705911
[TBL] [Abstract][Full Text] [Related]
16. SALL4 is a marker of the embryonal subtype of hepatoblastoma.
Gnemmi V; Leteurtre E; Sudour-Bonnange H; Devisme L; Guettier C; Buob D; Leroy X
Histopathology; 2013 Sep; 63(3):425-8. PubMed ID: 23822878
[TBL] [Abstract][Full Text] [Related]
17. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
[TBL] [Abstract][Full Text] [Related]
18. Cytomorphology of hepatoblastoma with histological correlation and role of SALL4 immunocytochemistry in its diagnosis, subtyping, and prognostication.
Nakra T; Roy M; Yadav R; Agarwala S; Jassim M; Khanna G; Das P; Jain D; Mathur SR; Iyer VK
Cancer Cytopathol; 2020 Mar; 128(3):190-200. PubMed ID: 31880869
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic implication of hepatic progenitor cell marker expression in hepatoblastoma.
Yun WJ; Shin E; Lee K; Jung HY; Kim SH; Park YN; Yu E; Jang JJ
Pathol Res Pract; 2013 Sep; 209(9):568-73. PubMed ID: 23920322
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
